Literature DB >> 19865183

Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice.

Chenhong Zhang1, Menghui Zhang, Shengyue Wang, Ruijun Han, Youfang Cao, Weiying Hua, Yuejian Mao, Xiaojun Zhang, Xiaoyan Pang, Chaochun Wei, Guoping Zhao, Yan Chen, Liping Zhao.   

Abstract

Both genetic variations and diet-disrupted gut microbiota can predispose animals to metabolic syndromes (MS). This study assessed the relative contributions of host genetics and diet in shaping the gut microbiota and modulating MS-relevant phenotypes in mice. Together with its wild-type (Wt) counterpart, the Apoa-I knockout mouse, which has impaired glucose tolerance (IGT) and increased body fat, was fed a high-fat diet (HFD) or normal chow (NC) diet for 25 weeks. DNA fingerprinting and bar-coded pyrosequencing of 16S rRNA genes were used to profile gut microbiota structures and to identify the key population changes relevant to MS development by Partial Least Square Discriminate Analysis. Diet changes explained 57% of the total structural variation in gut microbiota, whereas genetic mutation accounted for no more than 12%. All three groups with IGT had significantly different gut microbiota relative to healthy Wt/NC-fed animals. In all, 65 species-level phylotypes were identified as key members with differential responses to changes in diet, genotype and MS phenotype. Most notably, gut barrier-protecting Bifidobacterium spp. were nearly absent in all animals on HFD, regardless of genotype. Sulphate-reducing, endotoxin-producing bacteria of the family, Desulfovibrionaceae, were enhanced in all animals with IGT, most significantly in the Wt/HFD group, which had the highest calorie intake and the most serious MS phenotypes. Thus, diet has a dominating role in shaping gut microbiota and changes of some key populations may transform the gut microbiota of Wt animals into a pathogen-like entity relevant to development of MS, despite a complete host genome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19865183     DOI: 10.1038/ismej.2009.112

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  322 in total

Review 1.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations.

Authors:  Chenhong Zhang; Menghui Zhang; Xiaoyan Pang; Yufeng Zhao; Linghua Wang; Liping Zhao
Journal:  ISME J       Date:  2012-04-12       Impact factor: 10.302

3.  Genomics: The tale of our other genome.

Authors:  Liping Zhao
Journal:  Nature       Date:  2010-06-17       Impact factor: 49.962

Review 4.  Relationship between intestinal microbiota and colorectal cancer.

Authors:  Gokhan Cipe; Ufuk Oguz Idiz; Deniz Firat; Huseyin Bektasoglu
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

5.  Pregnancy-related changes in the maternal gut microbiota are dependent upon the mother's periconceptional diet.

Authors:  Wajiha Gohir; Fiona J Whelan; Michael G Surette; Caroline Moore; Jonathan D Schertzer; Deborah M Sloboda
Journal:  Gut Microbes       Date:  2015

Review 6.  Obesity and severe asthma.

Authors:  Hiroki Tashiro; Stephanie A Shore
Journal:  Allergol Int       Date:  2018-12-01       Impact factor: 5.836

Review 7.  'Inside Out'- a dialogue between mitochondria and bacteria.

Authors:  Bing Han; Chih-Chun Janet Lin; Guo Hu; Meng C Wang
Journal:  FEBS J       Date:  2018-11-21       Impact factor: 5.542

Review 8.  The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.

Authors:  Nicholas Dopkins; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

Review 9.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

10.  Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats.

Authors:  Jianzhao Huang; Nan Xiao; Yiying Sun; Shanshan Wu; Wenni Tian; Yujian Lai; Pan Li; Bing Du
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-31       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.